Disclosures for "NET-Inhibition with Ampreloxetine, Blood Pressure, and Catecholamines in Patients with Neurogenic Orthostatic Hypotension"
-
The institution of Valeria Iodice has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance .
-
The institution of Dr. Bryarly has received research support from Theravance.
-
Mr. Guerin has received personal compensation for serving as an employee of Theravance Biopharma.
-
Ross Vickery has nothing to disclose.
-
Prof. Norcliffe-Kaufmann has received personal compensation for serving as an employee of Theravance BioPharma. Prof. Norcliffe-Kaufmann has received personal compensation for serving as an employee of 23andMe.
-
Dr. Biaggioni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theravance biopharma. Dr. Biaggioni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance biopharma. The institution of Dr. Biaggioni has received research support from Theravance biopharma.
-
Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.